INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN
UNII DC4ELG1BFZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Influenza A Virus A/brisbane/02/2018 (h1n1) Recombinant Hemagglutinin Antigen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DC4ELG1BFZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DC4ELG1BFZ

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

DC4ELG1BFZ

The specific atomic composition represented as a molecular structure string.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Influenza A Virus A/brisbane/02/2018 (h1n1) Recombinant Hemagglutinin Antigen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.